Anne Rios obtained her PhD in 2011. Her work represented a novel cell signaling mechanism that triggers the differentiation of a defined subset of cells within a stem pool (Nature, 2011). She then joined the laboratory of Professor Visvader focusing on Breast Cancer. A researcher at the Walter and Eliza Hall Institute (WEHI) in Melbourne, she was awarded the Neil Lawrence prize at the 2016 Centenary Institute Medical Innovation Awards for her project entitled ‘A journey into the unexpected: A 3D view of breast cancer’ which represented her post-doctoral work (Nature, 2014). She has developed a new 3D imaging technique that allows scientists to visualize entire breast tissues down to a single-cell level. She is the only researcher in Australia – and one of the few in the world – to do this. In 2017, she was appointed group leader at the Princess Máxima Center and Head the Princess Máxima Imaging Centre. She is currently investigating the cellular mechanisms underlying pediatric solid tumor progression using State-of-the-art imaging technologies.
Innovative 3D imaging techniques to detect breast cancer.
Dr. Yusuke Yamamoto completed his Ph.D. in Molecular Physiology from Waseda University, Japan in 2008. He further pursued his postdoctoral studies under the supervision of Prof. Frank McKeon and A/Prof. Wa Xian at Genome Institute of Singapore. Presently, he is working as a Senior Staff Scientist at National Cancer Center Research Institute, Japan. He has been interested in how adult stem cells maintain their stemness throughout the lifespan as well as identifying cell-of-origin in esophageal adenocarcinomas and high grade serous ovarian carcinoma, which are the most aggressive type of cancers with poor prognosis. With his outstanding research work, he has published more than 40 papers in peer-reviewed journals, including Nature and Cell and holds one US patent on ‘Nanobio device of imitative anatomy structure’ in 2010 while another one, ‘Novel Diagnosis and Therapeutic Targets for Cervical Cancer’ is in the pipeline. He has presented his various research work in 15 national and international conferences and is a member of The Molecular Biology Society of Japan, Japanese Cancer Association and The Japanese Biochemical Society.
Dr. Alexander Birbrair started his scientific career from B.S. in Biomedical Sciences from Universidade Estadual de Santa Cruz, UESC, Ilheus, Brazil. He completed his Ph.D. in Neurosciences Program, particularly in the field of Stem Cell Biology, from Wake Forest School of Medicine, Winston-Salem, NC, USA. Dr. Birbrair received his Post-Doctoral Degree from Albert Einstein College of Medicine, Bronx, NY, USA in Stem Cell Biology and joined as a Professor at Department of Pathology, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil in 2016. He is a recipient of several notable awards and honours, which includes, Gordon A. Melson Outstanding Doctoral Student Award for 2015 and Editor's choice Award in Journal of Gerontology Biological Sciences Volume 69 Issue 12 December 2014 for the manuscript “Human Slow Troponin T (TNNT1) Pre-mRNA Alternative Splicing is An Indicator of Skeletal Muscle Response to Resistance Exercise in Older Adults.” by Zhang T, Choi SJ, Wang ZM, Birbrair A, Messi ML, Jin J-P, Marsh AP, Nicklas B, and Delbono O. He is an active member of American Heart Association, Western NC Chapter of the Society for Neuroscience and International Society for Stem Cell Research with more than 30 publications in peer-reviewed journals and serves as an ad hoc reviewer for 14 Journals related to pathology and stem cell biology.
Dr. Wa Xian received her Bachelor’s degree in Biochemistry from Nankai University in China and Ph.D. degree in Molecular Genetics at the University of Texas Graduate School of Biomedical Sciences in Houston, focusing on master regulator genes of cell proliferation and lineage specification during early neural development. The support of a DOD breast cancer fellowship enabled Dr. Xian’s postdoctoral studies with Prof. Jeffrey Rosen at the Baylor College of Medicine. There she used a combination of ligand-induced dimerization strategies and a mammary epithelial 3D culture system to address the role of fibroblast receptor tyrosine kinase signaling in the evolution of breast cancer. In 2008, Dr. Xian moved to Harvard Medical School under the direction of Prof. Christopher Crum, Director of Women’s and Perinatal Pathology at the Brigham and Women’s Hospital to study the origin and evolution of ovarian cancer. Dr. Xian continues to work very closely with Prof. Crum on the origins and chemotherapy resistance problem in high-grade ovarian cancer. In 2009, Dr. Xian was appointed Principal Investigator at the Institute of Medical Biology of the Agency for Science, Technology, and Research in Singapore, where she jointly oversaw a highly interactive group of postdoctoral fellows, graduate students, and research assistants with Prof Frank McKeon of the Genome Institute of Singapore devoted to the cloning of stem cells of regenerative tissues and using advanced technologies to understand the genetics of their self-renewal, commitment, and differentiation. In 2013, Dr. Xian returned to the US and initiated multiple projects related to inflammatory diseases and cancer with colleagues at the University of Connecticut Health Center. In 2015, Dr. Xian received the Rising Stars Award from the Cancer Prevention & Research Institute of Texas (CPRIT) and was recruited to the Institute of Molecular Medicine at the University of Texas Health Science Center in Houston.
Professor Ahmed Hashash has completed his PhD from Manchester University, UK. He is a fellow of the California Institute of Regenerative Medicine (CIRM) and New York University Medical School (MSSM), USA. Prof. Ahmed Hashash worked as a senior biomedical research scientist at Mount Sinai School of Medicine of New York University and Children’s Hospital Los Angeles. He was Assistant Professor and Principal Investigator of Stem Cell & Regenerative Medicine at Keck School of Medicine and Ostrow School of Dentistry of The University of Southern California, USA. In 2016, Prof. Hashash has joined The University of Edinburgh, Edinburgh Medical School-Zhejiang International Campus, (ZJU) as Tenure-Track Associate Professor and Senior Principal Investigator of Biomedicine, Stem Cell & Regenerative Medicine. He is also adjunct Professor at the School of Basic Medical Science and School of Medicine, Zhejiang University. Prof. Hashash has several breakthrough discoveries in genes/enzymes that control stem cell behavior and regenerative medicine. He has published more than 25 papers in reputed international journals and serving as an editorial board member of repute. Prof. El-Hashash acts as a discussion leader at the prestigious Gordon Research Seminar/Conference in USA, and a Peer Reviewer/ International Extramural Review for The Medical Research Council (MRC) grant applications, London, UK. He is invited to speak at several international conferences in USA, Spain, Greece, Egypt and China. He is the editor or author of several books on stem cell and regenerative medicine.
Dr. Woodring E. Wright received his BA degree, Summa Cum Laude, from Harvard University in 1970, a PhD under the direction of Dr. Leonard Hayflick in 1974 and an MD from Stanford University School of Medicine in 1975. Following a postdoctoral fellowship at the Pasteur Institute in Paris, France with Dr. Francois Gros, he joined the faculty at Southwestern Medical School in Dallas, Texas in 1978, where he is now Professor of Cell Biology and Southland Financial Corporation Distinguished Chair in Geriatric Research. He has been the recipient of the Lyndon Baines Johnson Research Award of the American Heart Association, a Research Career Development award from the NIH, a Merit Award from the National Institute on Aging, an AlliedSignal Award for Research on Aging, the Hayflick Award from American Aging Association and an Ellison Medical Foundation Senior Scholar Award. He is on the Scientific Advisory Board of the Buck Institute on Aging. He is the author of more than 200 scientific publications, and holds fifteen U.S. patents, with an additional eight pending.
Gallicchio earned his Ph.D. in Experimental Hematology at New York University Medical Center and completed fellowships in hematology at the Sloan Kettering Institute for Cancer Research and at the University of Connecticut Health Center. He was awarded a diploma in internal medicine from the “Vasile Goldis” University of Arad (Romania). He has served on the faculty at Yale University School of Medicine, University of Kentucky Medical Center, University of Central Lancashire (England), and University of Wolverhampton (England). He has served as President of Alpha Eta Honor Society, the International Society for Lithium Research, International Federation of Biomedical Laboratory Science and currently serves as Vice President of the Educational and Research Centers in Trace Elements operated under the auspice of UNESCO. He is a Fellow of the Association of Clinical Scientists, the Association of Schools of Allied Health Professions, and the Royal Society of the Arts. In 2003, at a 200th anniversary RSA event, because of his long-standing effort to educate and train biomedical laboratory science students from England, Dr. Gallicchio was recognized for his efforts by being presented to Her Majesty, Queen Elizabeth II. Dr. Vincent S. Gallicchio has 45 years experience in academic medicine and research covering experimental hematology, immunology, stem cell biology, and developmental therapeutics for human diseases such as AIDS and cancer. He has earned national and international recognition for his efforts. In a first time study reporting on academic scholarly productivity in the Journal of Clinical Laboratory Science, Dr. Gallicchio was rated the number one academic biomedical laboratory science researcher in the United States. His rating of 551 was nearly twice that of the next closest professor’s score of 285. Additionally, during his leadership, the academic program in Clinical Laboratory Science at the University of Kentucky Medical Center was rated the number one program of its kind among 127 in the nation. His passion for research, a high value placed on excellence, a strong reputation as an esteemed collaborator, and a tenacious desire to see a better therapies for human diseases brought to market speak to his overall character.
Bekir Cinar completed his Postdoctoral Fellowship, Boston Children’s Hospital, Harvard Medical School (HMS), Boston, MA (2002-2006) and Ph.D. from Department of Biochemistry and Molecular Genetics, School of Medicine University of Virginia, Charlottesville, VA (1995-2002), D.V.M., Veterinary Medical School, Ankara University, Ankara, Turkey (1987-1992). Currently he is working as Associate Professor, Department of Biological Sciences, Clark Atlanta University (CAU), Atlanta, GA 2015 to present. Presently, He is also member of the Center for Cancer Research and Therapeutic Development at CAU and a member of the NCI-designated Winship Comprehensive Cancer Center at Emory University. Prior to joining CAU, Dr. Cinar was Assistant Professor of Medicine-Hematology/Oncology and Biomedical Sciences at Cedars-Sinai Medical Center, where he was a member of Samuel Oschin Comprehensive Cancer Institute.
Dr. Feng Tao is an Associate Professor in the Department of Biomedical Sciences at Texas A&M University College of Dentistry. Dr. Tao received his RO1 award and Independent Scientist Award from NIH in 2012 and 2014, respectively. He has published more than 40 papers in peer-reviewed professional journals and he is serving as an editorial board member for some professional journals. Dr. Tao also served as an invited reviewer for NIH NRCS Study Section, Johns Hopkins ACCM Seed Grant, NSF-sponsored Pilot Funding at Louisiana State University, Arizona Biomedical Research Commission, Britain Israel Research and Academic Exchange Partnership Regenerative Medicine Initiative, Wings for Life?Spinal Cord Research Foundation in Austria, Department of Veterans Affairs Rehabilitation Research and Development Service Spinal Cord Injury and Neuropathic Pain Panel, and The French National Research Agency (ANR) in France.
Dr. Yong Li is an Associate Professor within the Center Stem Cell for Regenerative Medicine, and Center for Tissue Engineering and Aging Research at the Brown Foundation Institute of Molecular Medicine (IMM), UT Health. He also is appointed as an Associate Professor in the Department of Pediatric and Orthopedic Surgery, and Internal Medicine, UTHealth. Dr. Li accomplished his MD and Ph.D. training in China and was a general surgeon before he went to London of the United Kingdom in 1997. His first research career as a post-doctor fellow trained in Imperial College School of Medicine in the UK (1997-1999), and later as a postdoctoral research associate in Children’s Hospital of Pittsburgh of UPMC. He was promoted to a research assistant professor in 2002, assistant professor in 2004 (within a tenure-track system in 2006), and led his research team approach success in the field of adult stem cell, environmental motivation, anti-fibrosis in regeneration medicine. These projects also include the enlargement and application of adult stem cells (muscle and skin) to repair traumatic injury (muscle, tendon, spinal cord and brain) and congenital diseases. His academic career includes more than 100 peer-reviewed publications; over seven millions’ grant funding from NIH and DOD; over 50 training fellows and students; more than 28 national or international awards; over 30 times grant reviewer or panelist; service 10 journals’ editor boards; more than 50 times’ lecture in the conferences or seminars and 160 times of posters presentation in conferences.
Dr. M. James You completed his Ph.D from The University of Texas at Austin – 1997 and M.D. from Zhejiang University School of Medicine – 1986 and currently he is working as Associate Professor in Department of Hematopathology , The University of Texas MD Anderson Cancer Center, Houston, USA.